article · Discover Applied Sciences
Abstract The pharmacy industry is highly focused on drug discovery and development for the identification and optimization of potential drug candidates. One of the key aspects of this process is the prediction of various molecular properties that justify their potential effectiveness in treating specific diseases. Recently, graph neural networks have gained significant attention, primarily due to their strong suitability for predicting complex relationships that exist between atoms and other molecular structures. GNNs require significant depth to capture global features and to allow the network to iteratively aggregate and propagate information across the entire graph structure. In this research study, we present a deep learning architecture known as a graph molecular property prediction neural network. which combines MPNN feature extraction with a multilayer perceptron classifier. The deep learning architecture was evaluated on four benchmark datasets, and its performance was compared to the smiles transformer, fingerprint to vector, deeper graph convolutional networks, geometry-enhanced molecular, and atom-bond transformer-based message-passing neural network. The results showed that the architecture outperformed the other models using the receiver operating characteristic area under the curve metric. These findings offer an exciting opportunity to enhance and improve molecular property prediction in drug discovery and development.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s42452-024-05944-9
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.